Top Markets
Coin of the day
Delta-Fly Pharma, Inc. Delta-Fly Pharma, Inc.

Delta-Fly Pharma, Inc.

4598
株式のランク #32530
Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a... Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a biotechnology company focused on the development of innovative oncology drugs. Their comprehensive pipeline includes several drug candidates targeting various cancers. DFP-10917 is currently undergoing Phase III clinical evaluation in the United States and Phase I in Japan for relapsed/refractory acute myeloid leukemia. Another significant compound, DFP-14323, is in Phase III trials for lung cancer. The firm is also advancing DFP-17729 through Phase I/II studies for solid tumors. Furthermore, DFP-11207 has successfully completed its Phase I clinical trial for pancreatic cancer. For hematologic malignancies, DFP-14927 is in Phase I, while DFP-10825 is in preclinical development, targeting gastric and ovarian cancers.
株価
$0.69158324
時価総額
$9.84M
変化(1日)
0.00%
変化(1年)
-84.27%
JP
取引 Delta-Fly Pharma, Inc. (4598)

カテゴリー

Delta-Fly Pharma, Inc.(4598)の配当利回りの履歴
Delta-Fly Pharma, Inc.(銘柄コード: 4598)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Delta-Fly Pharma, Inc.(4598)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)
企業 配当利回り
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.48%
BE